South Korea’s fertility support program accounted for 48,981 births in 2025, according to the government’s 2026 report. That was 19.2% of all births. These program figures describe publicly supported fertility treatment, not IVF alone, and do not measure how many additional births the funding itself caused.
The Ministry of Health and Welfare’s report counted 48,981 births through the fertility-treatment support program in 2025, representing 19.2% of total births. The program includes treatment beyond IVF, so this is not an IVF-only birth share.
Reported program births rose by 31.4% from the previous year. Changes in coverage, reporting and treatment use matter when interpreting the increase; the count alone does not establish a causal funding effect.
Several factors shape demand
Age is relevant, alongside diagnoses, access and policy. IVF is not automatically the appropriate first treatment for everyone who starts a family later.
Success includes safety
Multiple pregnancy is an important concern in fertility care because of maternal and neonatal risks. Program-level birth counts should not be confused with an individual treatment’s multiple-pregnancy rate.
Single embryo transfer can substantially reduce multiple pregnancy associated with transferring more than one embryo. It does not eliminate twins or all pregnancy risks.
The Evolution of IVF: From “Success Rates” to “Systemic Health”
The future of IVF is moving beyond the simple goal of “conception.” It is expanding to encompass:
- Embryo care: Transparent discussion of available testing and its limitations.
- Maternal and newborn health: Monitor clinically meaningful outcomes, including multiple pregnancy.
- Appropriate treatment: Match care to a diagnosed need rather than a promise of optimization.
Compare like with like
International statistics use different treatments, reporting periods and denominators. Publicly supported births, all ART births and IVF cycles are distinct measures.
The policy question is how to provide equitable, effective care while monitoring outcomes for parents and children. A birth count is one important measure, not the entire assessment.
Disclaimer: This content is provided for informational purposes, based on public health and reproductive statistics. Medical judgments and treatment decisions must always be made in consultation with professional medical personnel. Image: AI-generated (ChatGPT, OpenAI) / Visual reference for illustrative purposes only.
Identify the reported measure
The birth figure is attributed to Korea’s Ministry of Health and Welfare in its May 2026 announcement. Supported births are not the same measure as a treatment success rate. Yonhap report on the Ministry announcement, 14 May 2026.
Related reading
IVF Funding in the UK and South Korea: Who Gets Another Chance?